CDH1 and lung cancer: Secondary and tertiary screening assays demonstrated that the optimized compound, herein referred to as ML327, de-represses E-cadherin expression in human SW620inv colon and H520 lung cancer cells and inhibits cell invasion in culture with little to no cytotoxicity at effective concentrations.